1. Home
  2. PSTV vs ILAG Comparison

PSTV vs ILAG Comparison

Compare PSTV & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • ILAG
  • Stock Information
  • Founded
  • PSTV 1996
  • ILAG N/A
  • Country
  • PSTV United States
  • ILAG Hong Kong
  • Employees
  • PSTV N/A
  • ILAG N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • ILAG Office Equipment/Supplies/Services
  • Sector
  • PSTV Health Care
  • ILAG Consumer Discretionary
  • Exchange
  • PSTV Nasdaq
  • ILAG Nasdaq
  • Market Cap
  • PSTV 9.9M
  • ILAG 14.0M
  • IPO Year
  • PSTV N/A
  • ILAG 2022
  • Fundamental
  • Price
  • PSTV $1.75
  • ILAG $0.72
  • Analyst Decision
  • PSTV Strong Buy
  • ILAG
  • Analyst Count
  • PSTV 1
  • ILAG 0
  • Target Price
  • PSTV $8.00
  • ILAG N/A
  • AVG Volume (30 Days)
  • PSTV 59.7K
  • ILAG 227.0K
  • Earning Date
  • PSTV 08-12-2024
  • ILAG 08-06-2024
  • Dividend Yield
  • PSTV N/A
  • ILAG N/A
  • EPS Growth
  • PSTV N/A
  • ILAG N/A
  • EPS
  • PSTV N/A
  • ILAG N/A
  • Revenue
  • PSTV $6,084,000.00
  • ILAG $6,443,357.00
  • Revenue This Year
  • PSTV $5.21
  • ILAG N/A
  • Revenue Next Year
  • PSTV N/A
  • ILAG N/A
  • P/E Ratio
  • PSTV N/A
  • ILAG N/A
  • Revenue Growth
  • PSTV 733.42
  • ILAG N/A
  • 52 Week Low
  • PSTV $0.97
  • ILAG $0.33
  • 52 Week High
  • PSTV $3.21
  • ILAG $1.19
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 47.92
  • ILAG 65.22
  • Support Level
  • PSTV $1.62
  • ILAG $0.63
  • Resistance Level
  • PSTV $1.92
  • ILAG $1.02
  • Average True Range (ATR)
  • PSTV 0.17
  • ILAG 0.12
  • MACD
  • PSTV 0.03
  • ILAG 0.03
  • Stochastic Oscillator
  • PSTV 52.24
  • ILAG 54.29

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.

Share on Social Networks: